LLY

985.76

+1.21%↑

JNJ

223.6

+0.4%↑

ABBV

205.36

+0.4%↑

UNH

382.72

+1.72%↑

AZN

184.08

-0.73%↓

LLY

985.76

+1.21%↑

JNJ

223.6

+0.4%↑

ABBV

205.36

+0.4%↑

UNH

382.72

+1.72%↑

AZN

184.08

-0.73%↓

LLY

985.76

+1.21%↑

JNJ

223.6

+0.4%↑

ABBV

205.36

+0.4%↑

UNH

382.72

+1.72%↑

AZN

184.08

-0.73%↓

LLY

985.76

+1.21%↑

JNJ

223.6

+0.4%↑

ABBV

205.36

+0.4%↑

UNH

382.72

+1.72%↑

AZN

184.08

-0.73%↓

LLY

985.76

+1.21%↑

JNJ

223.6

+0.4%↑

ABBV

205.36

+0.4%↑

UNH

382.72

+1.72%↑

AZN

184.08

-0.73%↓

Home・Lista de Ações・Microbot Medical Inc

Microbot Medical Inc

Fechado

2.18 2.35

Comprar Vender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

2.14

Máximo

2.24

Indicadores-chave
By Trading Economics
Rendimento	113K -3.5M
Funcionários	43
EBITDA	-561K -4.1M

Recomendações
By TipRanks
Recomendações	Comprar
Previsão para 12 meses	+299.54% upside

Dividendos
By Dow Jones
Próximos Ganhos	12 de mai. de 2026

Estatísticas de Mercado
By TradingEconomics
Capitalização de Mercado	-28M 142M
Abertura anterior	-0.17
Fecho anterior	2.18

Pontuação Técnica

By Trading Central

Confiança

Neutral Evidence

2.52 / 2.57 Suporte e Resistência

Microbot Medical Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

11 de mai. de 2026, 22:15 UTC

Aquisições, Fusões, Aquisições de Empresas

BMO Financial Group to Sell Transportation-, Vendor-Finance Businesses to Stonepeak

11 de mai. de 2026, 23:46 UTC

Conversa de Mercado

Yen Consolidates as Traders Await Bessent's Meetings -- Market Talk

11 de mai. de 2026, 23:44 UTC

Conversa de Mercado

Nikkei May Rise on AI Enthusiasm -- Market Talk

11 de mai. de 2026, 23:33 UTC

Conversa de Mercado

Gold Rises on Possible Position Adjustments -- Market Talk

11 de mai. de 2026, 22:37 UTC

Conversa de Mercado

CSL's Profit, Revenue Downgrade 'Not a Complete Surprise' -- Market Talk

11 de mai. de 2026, 22:32 UTC

Ganhos

Verde Clean Fuels 1Q Loss/Shr 5c >VGAS

11 de mai. de 2026, 22:02 UTC

Conversa de Mercado

Notícias Principais

Stellar Auto Sales Increase in Canada Could Be Tied to Return of EV Incentives -- Market Talk

11 de mai. de 2026, 21:49 UTC

Ganhos

Rigetti Computing Revenue Triples. Why the Quantum Stock Is Falling. -- Barrons.com

11 de mai. de 2026, 21:42 UTC

Conversa de Mercado

Declining Hours Worked Should Keep Bank of Canada Firmly on Hold -- Market Talk

11 de mai. de 2026, 21:32 UTC

Aquisições, Fusões, Aquisições de Empresas

Bank of Montreal to Sell Transportation Finance and Vendor Finance Businesses to Stonepeak

11 de mai. de 2026, 21:32 UTC

Aquisições, Fusões, Aquisições de Empresas

BMO: Supports Strategy to Elevate Returns and Accelerate Growth, Transaction Accretive to Cap Ratios and ROE >BMO.T

11 de mai. de 2026, 21:32 UTC

Aquisições, Fusões, Aquisições de Empresas

BMO: Positions Businesses for Continued Growth in Efficient Cap Structure >BMO.T

11 de mai. de 2026, 21:32 UTC

Aquisições, Fusões, Aquisições de Empresas

BMO: To Invest in 19.9% Equity Interest, Enabling Continued Participation in the Businesses' Long-Term Value Creation >BMO.T

11 de mai. de 2026, 21:31 UTC

Aquisições, Fusões, Aquisições de Empresas

BMO: Announces Strategic Sale of Transportation and Vendor Finance Businesses

11 de mai. de 2026, 21:23 UTC

Aquisições, Fusões, Aquisições de Empresas

CSG Systems Sale to NEC Gets CFIUS Clearance

11 de mai. de 2026, 21:12 UTC

Ganhos

Ovintiv: Full-Yr Production Volumes Expected to Avg 620 to 645 MBOE/d, Full-Yr Expected Cap Investment of $2.25B to $2.35B >OVV

11 de mai. de 2026, 21:12 UTC

Ganhos

Ovintiv 1Q Loss/Shr $2.35 >OVV

11 de mai. de 2026, 20:50 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk

11 de mai. de 2026, 20:44 UTC

Ganhos

Steris: Board Approves New $1B Shr Repurchase Program >STE

11 de mai. de 2026, 20:43 UTC

Ganhos

Whirlpool Shares Are Still Falling. Last Week's Earnings Might Be Why. -- Barrons.com

11 de mai. de 2026, 20:32 UTC

Ganhos

CleanSpark 2Q Loss/Shr $1.52 >CLSK

11 de mai. de 2026, 20:32 UTC

Ganhos

CleanSpark 2Q Rev $136.4M >CLSK

11 de mai. de 2026, 20:30 UTC

Ganhos

Hims & Hers Stock Sinks. Why Earnings Offered Wall Street a Big Surprise. -- Barrons.com

11 de mai. de 2026, 20:30 UTC

Ganhos

Steris 4Q Cont Ops EPS $2.24 >STE

11 de mai. de 2026, 20:30 UTC

Ganhos

Steris 4Q Rev $1.6B >STE

11 de mai. de 2026, 20:30 UTC

Ganhos

Steris Sees FY Adj EPS $11.10-Adj EPS $11.30 >STE

11 de mai. de 2026, 20:30 UTC

Ganhos

Steris 4Q Adj EPS $2.83 >STE

11 de mai. de 2026, 20:22 UTC

Ações em Alta

Stocks to Watch: Moderna, Intel, Micron, Fox -- WSJ

11 de mai. de 2026, 19:37 UTC

Ganhos

More Bad News at KKR's Private Credit Fund -- Barrons.com

11 de mai. de 2026, 19:32 UTC

Conversa de Mercado

Oil Gains As Trump Rejects Iran's Response to U.S. Plan -- Market Talk

Comparação entre Pares

Variação de preço

Microbot Medical Inc Previsão

Preço-alvo

By TipRanks

299.54% parte superior

Previsão para 12 meses

Média 8.75 USD 299.54%

Máximo 12 USD

Mínimo 5.5 USD

Com base em 2 analistas de Wall Street que oferecem metas de preço de 12 meses para Microbot Medical Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

2 ratings

Comprar

Manter

Vender

Com base em 2 analistas que deram avaliações de ações para Microbot Medical Inc - Dist nos últimos 3 meses.

Pontuação Técnica

By Trading Central

2.52 / 2.57Suporte e Resistência

The bullish and bearish events are balanced.

Recent bullish events outweigh bearish events.

All events are bullish.

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

Sobre Microbot Medical Inc

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development; and Phase 2 collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.